Patient in a clinical trial who has satisfied all protocol requirements and may be evaluated for safety and efficacy in the analysis.
可评价患者完全符合临床试验方案的要求，可用于评价试验药物安全性和有效性的患者。
A design for randomized protocol of multi-center clinical trial dealing with multi-subtype disease and unequally distributed cases in centers was introduced in this article.
介绍多种疾病亚型、各中心分配例数不等的临床试验随机化方案的设计。
Treatment within the trial protocol was not associated with significant clinical benefit, although the study was underpowered and alternatie results cannot be excluded.
治疗没有显著的临床益处，虽然检验功效不够大，并不能排除有差异的结果。
Conclusions: The tolerance induction protocol significantly prolonged cardiac allograft survival in rat, and it appears to be worthy of a clinical trial. This tolerance involved multiple mechanisms.
结论：本诱导方案能明显延长异基因异位大鼠心脏移植物存活时间，是便于临床推广应用的一种有效方法，该移植耐受的形成涉及多种机制。
Conclusions: The tolerance induction protocol significantly prolonged cardiac allograft survival in rat, and it appears to be worthy of a clinical trial. This tolerance involved multiple mechanisms.
结论：本诱导方案能明显延长异基因异位大鼠心脏移植物存活时间，是便于临床推广应用的一种有效方法，该移植耐受的形成涉及多种机制。
应用推荐